Crossmark

Development of a Prophylactic mRNA Vaccine for Severe Fever with Thrombocytopenia Syndrome Using HSA based LNP

Published Online: 2026-02-25

Authors

Ganbold, Tsenddari

Lkhagva, Enkhchimeg

Munkhtur, Enkhtsatsral

Acharya, Satabdi

Kim, Hyeon Jin

Hong, Seong-Tschool
Funding

Funding for this research was provided by:

National Research Foundation of Korea (HV22C1234.)
License Information

Text and Data Mining valid from 2026-02-25

Accepted Manuscript valid from 2026-02-25
More Information

Article History

Received: 7 May 2025

Accepted: 19 January 2026

First Online: 25 February 2026

Competing interests

: The authors declare no competing interests.

Document is current